JNJ

234.6

+0.18%↑

UNH

275.89

-2.31%↓

TMO

570.38

-1.39%↓

ABT

108.46

+0.03%↑

ISRG

474.71

-2.33%↓

JNJ

234.6

+0.18%↑

UNH

275.89

-2.31%↓

TMO

570.38

-1.39%↓

ABT

108.46

+0.03%↑

ISRG

474.71

-2.33%↓

JNJ

234.6

+0.18%↑

UNH

275.89

-2.31%↓

TMO

570.38

-1.39%↓

ABT

108.46

+0.03%↑

ISRG

474.71

-2.33%↓

JNJ

234.6

+0.18%↑

UNH

275.89

-2.31%↓

TMO

570.38

-1.39%↓

ABT

108.46

+0.03%↑

ISRG

474.71

-2.33%↓

JNJ

234.6

+0.18%↑

UNH

275.89

-2.31%↓

TMO

570.38

-1.39%↓

ABT

108.46

+0.03%↑

ISRG

474.71

-2.33%↓

Home・Lista de Ações・Charles River Laboratories International Inc

Charles River Laboratories International Inc

Abrir

SetorSaúde

201.6 -1.03

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

199.16

Máximo

203.52

Indicadores-chave
By Trading Economics
Rendimento	2.9M 56M
Vendas	-27M 1B
EPS	2.43
Margem de lucro	5.529
Funcionários	18,700
EBITDA	-23M 198M

Recomendações
By TipRanks
Recomendações	Comprar
Previsão para 12 meses	+3.91% upside

Dividendos
By Dow Jones
Próximos Ganhos	18 de fev. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	2.1B 11B
Abertura anterior	202.63
Fecho anterior	201.6

Sentimento de Notícias

By Acuity

50%

152 / 352 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bullish Evidence

117.16 / 144.77 Suporte e Resistência

Charles River Laboratories International Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

3 de fev. de 2026, 23:11 UTC

Grandes Movimentos do Mercado

Aquisições, Fusões, Aquisições de Empresas

Silicon Laboratories Shares Up On Report of $7 Billion Texas Instruments Acquisition Deal

3 de fev. de 2026, 23:50 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

3 de fev. de 2026, 23:50 UTC

Conversa de Mercado

Nikkei May Decline After Hitting All-Time High -- Market Talk

3 de fev. de 2026, 23:42 UTC

Conversa de Mercado

Gold Edges Lower on Possible Technical Correction -- Market Talk

3 de fev. de 2026, 23:41 UTC

Aquisições, Fusões, Aquisições de Empresas

KKR Makes AI Play With $10.9B Asia Data-Center Deal

3 de fev. de 2026, 23:38 UTC

Ganhos

AMD Sales Climb on Help From Data-Center Business -- Update

3 de fev. de 2026, 23:29 UTC

Aquisições, Fusões, Aquisições de Empresas

KKR-Consortium Deal in STT GDC Is One of the Largest Digital-Infrastructure Transactions in Southeast Asia

3 de fev. de 2026, 23:27 UTC

Aquisições, Fusões, Aquisições de Empresas

Netflix, Warner Defend Proposed Deal in Senate Hearing -- WSJ

3 de fev. de 2026, 23:25 UTC

Aquisições, Fusões, Aquisições de Empresas

KKR-Consortium Expects Deal to Close by Early 2H of 2026

3 de fev. de 2026, 23:23 UTC

Aquisições, Fusões, Aquisições de Empresas

KKR Consortium With Singtel to Own 75% and 25% Stake in ST Telemedia Global Data Centres

3 de fev. de 2026, 23:22 UTC

Aquisições, Fusões, Aquisições de Empresas

KKR-Led Consortium to Buy Singapore-Based Global Data-Center Provider Valued at S$13.8B

3 de fev. de 2026, 23:19 UTC

Conversa de Mercado

Australia Gold Miners Tipped to Rally Higher -- Market Talk

3 de fev. de 2026, 23:19 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

3 de fev. de 2026, 22:56 UTC

Grandes Movimentos do Mercado

Aquisições, Fusões, Aquisições de Empresas

Silicon Laboratories Shares Up On Report of $7B Texas Instruments Acquisition Deal

3 de fev. de 2026, 22:40 UTC

Ganhos

Amdocs Extends Collaboration With T-Mobile

3 de fev. de 2026, 22:39 UTC

Ganhos

Amdocs 1Q Adj EPS $1.81

3 de fev. de 2026, 22:39 UTC

Ganhos

Amdocs 1Q Rev $1.16B

3 de fev. de 2026, 22:39 UTC

Ganhos

Amdocs 1Q EPS $1.45 >

3 de fev. de 2026, 22:38 UTC

Ganhos

Amdocs: Shimie Hortig to Succeed Shuky Sheffer as President and CEO, Effective March 31

3 de fev. de 2026, 22:30 UTC

Aquisições, Fusões, Aquisições de Empresas

Bob Iger's Second Time as CEO Wasn't Great for the Stock. He Still Leaves Behind A Strong Legacy. -- Barrons.com

3 de fev. de 2026, 22:22 UTC

Aquisições, Fusões, Aquisições de Empresas

Texas Instruments Nearing $7B Deal for Silicon Laboratories, Sources Tell FT

3 de fev. de 2026, 22:14 UTC

Ganhos

AMD Expects to Scale AI Business to Tens of Billions in Annual Sales in 2027, CEO Says

3 de fev. de 2026, 22:13 UTC

Ganhos

AMD Expects Data-Center Unit Sales to Jump More Than 60% a Year Over Next Three to Five Years, CEO Says

3 de fev. de 2026, 22:12 UTC

Ganhos

AMD in Talks With Several Companies About At-Scale, Multi-Year Chip Deployments, CEO Says

3 de fev. de 2026, 22:10 UTC

Ganhos

AMD CEO: Eight of 10 Biggest AI Companies Use Instinct Chip to Power Production Workloads

3 de fev. de 2026, 22:10 UTC

Ganhos

Blackstone Stock, Alternative Managers, BDCs Dive as Software Woes Infect Private Credit -- Barrons.com

3 de fev. de 2026, 22:10 UTC

Conversa de Mercado

Key Drivers Underpinning Shaw's Bullish View of Gold Intact -- Market Talk

3 de fev. de 2026, 22:10 UTC

Ganhos

AMD CEO: Enterprises Are Modernizing Data Centers to Have Compute Needed for New AI Workflows

3 de fev. de 2026, 22:09 UTC

Ganhos

AMD CEO: Hyperscalers Expanding Infrastructure to Meet Growing Cloud-Services Demand in AI

3 de fev. de 2026, 22:09 UTC

Ganhos

AMD CEO: Demand Accelerated Across Data Center, Gaming and PC

Comparação entre Pares

Variação de preço

Charles River Laboratories International Inc Previsão

Preço-alvo

By TipRanks

3.91% parte superior

Previsão para 12 meses

Média 221.55 USD 3.91%

Máximo 265 USD

Mínimo 170 USD

Com base em 13 analistas de Wall Street que oferecem metas de preço de 12 meses para Charles River Laboratories International Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

13 ratings

Comprar

Manter

Vender

Com base em 13 analistas que deram avaliações de ações para Charles River Laboratories International Inc - Dist nos últimos 3 meses.

Pontuação Técnica

By Trading Central

117.16 / 144.77Suporte e Resistência

Recent bullish events outweigh bearish events.

All events are bearish.

Sentimento

By Acuity

152 / 352 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Charles River Laboratories International Inc

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It also provides contract vivarium operation services to biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.